104 related articles for article (PubMed ID: 27717655)
21. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
[TBL] [Abstract][Full Text] [Related]
22. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.
Hsu KH; Carbia BE; Plummer C; Chauhan A
Eur J Pharm Biopharm; 2015 Aug; 94():312-21. PubMed ID: 26071799
[TBL] [Abstract][Full Text] [Related]
23. Bimatoprost versus timolol and dorzolamide.
Tressler CS
Ophthalmology; 2005 Feb; 112(2):357-8; author reply 358-9. PubMed ID: 15691575
[No Abstract] [Full Text] [Related]
24. The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma.
van Gestel A; Webers CA; Severens JL; Beckers HJ; Jansonius NM; Hendrikse F; Schouten JS
Acta Ophthalmol; 2012 Feb; 90(1):20-31. PubMed ID: 22289192
[TBL] [Abstract][Full Text] [Related]
25. Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy.
Inoue K; Okugawa K; Kato S; Inoue Y; Tomita G; Oshika T; Amano S
J Glaucoma; 2003 Dec; 12(6):480-5. PubMed ID: 14646683
[TBL] [Abstract][Full Text] [Related]
26. [Raynaud syndrome following timolol-containing eyedrops].
Meuche C; Heidrich H; Bleckmann H
Fortschr Ophthalmol; 1990; 87(1):45-7. PubMed ID: 2323696
[TBL] [Abstract][Full Text] [Related]
27. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial assessing dorzolamide in patients with glaucoma who are younger than 6 years.
Ott EZ; Mills MD; Arango S; Getson AJ; Assaid CA; Adamsons IA
Arch Ophthalmol; 2005 Sep; 123(9):1177-86. PubMed ID: 16157797
[TBL] [Abstract][Full Text] [Related]
29. Update in glaucoma: the new pharmacotherapies. Dorzolamide hydrochloride.
Gould LF
Can J Ophthalmol; 1998 Aug; 33(5):253-4; discussion 257-8. PubMed ID: 9740951
[No Abstract] [Full Text] [Related]
30. The effects of combination glaucoma medications on ocular surface epithelial cells.
Ammar DA; Kahook MY
Adv Ther; 2009 Oct; 26(10):970-5. PubMed ID: 19921496
[TBL] [Abstract][Full Text] [Related]
31. Modern alchemy: fixed combinations of glaucoma drugs.
Katz LJ
Am J Ophthalmol; 2005 Jul; 140(1):125-6. PubMed ID: 16038653
[No Abstract] [Full Text] [Related]
32. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
Boyle JE; Ghosh K; Gieser DK; Adamsons IA
Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart.
Kim YI; Kim JH; Lee TY; Lee KW
J Ocul Pharmacol Ther; 2015; 31(6):335-9. PubMed ID: 26133057
[TBL] [Abstract][Full Text] [Related]
34. Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy.
Goldberg I; Crowston JG; Jasek MC; Stewart JA; Stewart WC;
J Glaucoma; 2012 Jan; 21(1):55-9. PubMed ID: 21048504
[TBL] [Abstract][Full Text] [Related]
35. Bullous pemphigoid possibly triggered and exacerbated by ophthalmic preparations.
Spivak D; Orion E; Brenner S
Int J Dermatol; 2000 Jul; 39(7):554-5. PubMed ID: 10940126
[No Abstract] [Full Text] [Related]
36. The clinical impact of 2 different strategies for initiating therapy in patients with ocular hypertension.
Peeters A; Webers CA; Prins MH; Hendrikse F; Schouten JS
J Glaucoma; 2011 Jan; 20(1):30-6. PubMed ID: 21191272
[TBL] [Abstract][Full Text] [Related]
37. Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Cvenkel B; Stewart JA; Nelson LA; Stewart WC
Curr Eye Res; 2008 Feb; 33(2):163-8. PubMed ID: 18293187
[TBL] [Abstract][Full Text] [Related]
38. A six-week, parallel, randomized, double-blind study comparing the efficacy and safety of the 0.5% timolol/2.0% MK-507 combination b.i.d. to the concomitant administration of 0.5% timolol b.i.d. and 2.0% MK-507 b.i.d.
Chen YF; Yang CH; Hung PT
J Ocul Pharmacol Ther; 2003 Oct; 19(5):417-23. PubMed ID: 14583134
[TBL] [Abstract][Full Text] [Related]
39. Consultation Section: Glaucoma. Management of cataract and glaucoma in patient with a preexisting Cypass microstent in fellow eye: January consultation #1.
Samuelson TW
J Cataract Refract Surg; 2019 Jan; 45(1):105. PubMed ID: 30579514
[No Abstract] [Full Text] [Related]
40. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
Adamsons IA; Polis A; Ostrov CS; Boyle JE
J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
